24.71
price down icon1.89%   -0.475
 
loading
Precedente Chiudi:
$25.19
Aprire:
$25.28
Volume 24 ore:
6.68M
Relative Volume:
0.61
Capitalizzazione di mercato:
$10.36B
Reddito:
$5.06B
Utile/perdita netta:
$-2.22B
Rapporto P/E:
-4.2466
EPS:
-5.82
Flusso di cassa netto:
$-3.96B
1 W Prestazione:
+0.88%
1M Prestazione:
-28.80%
6M Prestazione:
-54.92%
1 anno Prestazione:
-76.11%
Intervallo 1D:
Value
$24.43
$25.28
Intervallo di 1 settimana:
Value
$24.26
$27.21
Portata 52W:
Value
$23.15
$170.47

Moderna Inc Stock (MRNA) Company Profile

Name
Nome
Moderna Inc
Name
Telefono
(617) 714-6500
Name
Indirizzo
325 BINNEY STREET, CAMBRIDGE
Name
Dipendente
5,800
Name
Cinguettio
@moderna_tx
Name
Prossima data di guadagno
2025-02-14
Name
Ultimi documenti SEC
Name
MRNA's Discussions on Twitter

Confronta MRNA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MRNA
Moderna Inc
24.71 10.36B 5.06B -2.22B -3.96B -5.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.10 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.16 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
596.20 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
234.56 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Iniziato Citigroup Neutral
2025-02-18 Downgrade Barclays Overweight → Equal Weight
2025-01-29 Downgrade Goldman Buy → Neutral
2024-12-18 Downgrade Argus Buy → Hold
2024-12-10 Ripresa BofA Securities Underperform
2024-11-19 Iniziato Berenberg Hold
2024-11-18 Aggiornamento HSBC Securities Hold → Buy
2024-11-15 Iniziato Wolfe Research Underperform
2024-10-17 Iniziato Bernstein Mkt Perform
2024-09-13 Downgrade JP Morgan Neutral → Underweight
2024-09-13 Downgrade Jefferies Buy → Hold
2024-09-13 Downgrade Oppenheimer Outperform → Perform
2024-08-28 Aggiornamento HSBC Securities Reduce → Hold
2024-08-07 Aggiornamento Deutsche Bank Sell → Hold
2024-08-05 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-02-26 Downgrade HSBC Securities Hold → Reduce
2024-01-02 Aggiornamento Oppenheimer Perform → Outperform
2023-11-29 Iniziato Canaccord Genuity Hold
2023-11-03 Aggiornamento HSBC Securities Reduce → Hold
2023-11-02 Downgrade Deutsche Bank Hold → Sell
2023-08-04 Downgrade TD Cowen Outperform → Market Perform
2023-08-03 Downgrade Deutsche Bank Buy → Hold
2023-07-24 Iniziato William Blair Mkt Perform
2023-07-14 Iniziato HSBC Securities Reduce
2023-06-26 Aggiornamento UBS Neutral → Buy
2023-04-26 Iniziato Guggenheim Neutral
2023-03-13 Aggiornamento TD Cowen Market Perform → Outperform
2023-03-02 Iniziato RBC Capital Mkts Outperform
2023-02-24 Downgrade SVB Securities Market Perform → Underperform
2022-12-19 Aggiornamento Jefferies Hold → Buy
2022-12-14 Downgrade Chardan Capital Markets Buy → Neutral
2022-10-21 Aggiornamento SVB Leerink Underperform → Mkt Perform
2022-09-08 Aggiornamento Deutsche Bank Hold → Buy
2022-02-01 Aggiornamento Redburn Sell → Neutral
2022-01-26 Aggiornamento Deutsche Bank Sell → Hold
2022-01-21 Aggiornamento BofA Securities Underperform → Neutral
2022-01-21 Iniziato UBS Neutral
2021-12-07 Iniziato Cowen Market Perform
2021-11-09 Iniziato Wolfe Research Outperform
2021-10-22 Iniziato Deutsche Bank Sell
2021-10-15 Aggiornamento Piper Sandler Neutral → Overweight
2021-08-06 Downgrade Oppenheimer Outperform → Perform
2021-08-06 Downgrade Piper Sandler Overweight → Neutral
2021-07-15 Reiterato Jefferies Hold
2021-02-01 Downgrade BofA Securities Neutral → Underperform
2020-12-16 Downgrade Jefferies Buy → Hold
2020-12-16 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-12-09 Downgrade Needham Buy → Hold
2020-11-23 Iniziato Wells Fargo Equal Weight
2020-11-17 Downgrade BMO Capital Markets Outperform → Market Perform
2020-09-08 Downgrade SVB Leerink Mkt Perform → Underperform
2020-07-23 Iniziato SVB Leerink Mkt Perform
2020-07-20 Downgrade JP Morgan Overweight → Neutral
2020-07-13 Iniziato Jefferies Buy
2020-06-30 Iniziato Argus Buy
2020-06-08 Iniziato Barclays Overweight
2020-04-30 Iniziato BMO Capital Markets Outperform
2020-03-05 Downgrade BofA/Merrill Buy → Neutral
2019-12-03 Ripresa BofA/Merrill Buy
2019-10-25 Iniziato ROTH Capital Buy
2019-04-05 Iniziato Chardan Capital Markets Buy
Mostra tutto

Moderna Inc Borsa (MRNA) Ultime notizie

pulisher
Apr 18, 2025

Russell Investments Group Ltd. Increases Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 18, 2025
pulisher
Apr 18, 2025

Bank of Montreal Can Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 18, 2025
pulisher
Apr 18, 2025

Moderna sues construction firm claiming leaks, mold at new drug plant - NBC Boston

Apr 18, 2025
pulisher
Apr 18, 2025

Bridgewater Associates LP Invests $25.19 Million in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 18, 2025
pulisher
Apr 18, 2025

Water leaks, mold plague Moderna's new manufacturing site, lawsuit claims - The Business Journals

Apr 18, 2025
pulisher
Apr 18, 2025

Scotia Capital Inc. Decreases Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 18, 2025
pulisher
Apr 18, 2025

Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Apr 18, 2025
pulisher
Apr 17, 2025

Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance

Apr 17, 2025
pulisher
Apr 17, 2025

US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years - Benzinga

Apr 17, 2025
pulisher
Apr 17, 2025

Invesco Ltd. Acquires 979,858 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 17, 2025
pulisher
Apr 17, 2025

Moderna Says New Drug Plant Riddled With Defects, Mold - Law360

Apr 17, 2025
pulisher
Apr 17, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Legal & General Group Plc - MarketBeat

Apr 17, 2025
pulisher
Apr 17, 2025

Moderna (MRNA) Leads Healthcare Short Interest in March - GuruFocus

Apr 17, 2025
pulisher
Apr 17, 2025

Lansdowne Partners UK LLP Acquires New Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 17, 2025
pulisher
Apr 17, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Advisory Services Network LLC - MarketBeat

Apr 17, 2025
pulisher
Apr 17, 2025

Quinn Opportunity Partners LLC Invests $686,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 17, 2025
pulisher
Apr 17, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Neuberger Berman Group LLC - MarketBeat

Apr 17, 2025
pulisher
Apr 16, 2025

Bloom Energy, Rogers, 3D Systems, Moderna, and EchoStar Stocks Trade Down, What You Need To Know - The Globe and Mail

Apr 16, 2025
pulisher
Apr 16, 2025

Moderna permitted to start commercial mRNA vaccine manufacture in UK - The Pharma Letter

Apr 16, 2025
pulisher
Apr 16, 2025

Leerink Partners Adjusts Moderna Price Target to $23 From $27, Maintains Underperform Rating - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

Moderna Co-Founder and MIT Legend Strengthens Decoy Therapeutics Drug Development Team - Stock Titan

Apr 16, 2025
pulisher
Apr 16, 2025

MRNA Based Vaccines and Therapeutics Therapeutics Market Size - openPR.com

Apr 16, 2025
pulisher
Apr 16, 2025

APG Asset Management N.V. Has $9.15 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 16, 2025
pulisher
Apr 15, 2025

Renaissance Technologies LLC Purchases 700,458 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 15, 2025
pulisher
Apr 15, 2025

FDA Special Assistant Høeg’s Vaccine Concerns On Display At ACIP - insights.citeline.com

Apr 15, 2025
pulisher
Apr 15, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Shelton Capital Management - MarketBeat

Apr 15, 2025
pulisher
Apr 15, 2025

Goldman Sachs Adjusts Moderna's Price Target to $35 From $49, Keeps Neutral Rating - MarketScreener

Apr 15, 2025
pulisher
Apr 14, 2025

Redburn Atlantic Adjusts Moderna's Price Target to $52 From $55, Keeps Neutral Rating - MarketScreener

Apr 14, 2025
pulisher
Apr 14, 2025

Morgan Stanley Issues Pessimistic Forecast for Moderna (NASDAQ:MRNA) Stock Price - MarketBeat

Apr 14, 2025
pulisher
Apr 13, 2025

Aviva PLC Lowers Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 13, 2025
pulisher
Apr 13, 2025

Resona Asset Management Co. Ltd. Buys Shares of 94,753 Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 13, 2025
pulisher
Apr 13, 2025

Fmr LLC Has $776.08 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 13, 2025
pulisher
Apr 12, 2025

Sit Investment Associates Inc. Sells 10,675 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 12, 2025
pulisher
Apr 12, 2025

Moderna (NASDAQ:MRNA) Sets New 1-Year LowTime to Sell? - MarketBeat

Apr 12, 2025
pulisher
Apr 12, 2025

Lobbying Update: $50,000 of MODERNA US INC. lobbying was just disclosed - Nasdaq

Apr 12, 2025
pulisher
Apr 12, 2025

RFK Jr Asks If Taxpayer-Funded Healthcare Should Be Accessible To People Smoking 'Three Packs A Day' - Benzinga

Apr 12, 2025
pulisher
Apr 11, 2025

11,987 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Aster Capital Management DIFC Ltd - MarketBeat

Apr 11, 2025
pulisher
Apr 11, 2025

First Week of May 30th Options Trading For Moderna (MRNA) - Nasdaq

Apr 11, 2025
pulisher
Apr 11, 2025

National Bank of Canada FI Sells 66,191 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 11, 2025
pulisher
Apr 10, 2025

Himension Capital Singapore PTE. LTD. Purchases 21,102 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

87,970 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by ExodusPoint Capital Management LP - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Titleist Asset Management LLC Has $1.31 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Moderna to Report First Quarter 2025 Financial Results on Thursd - GuruFocus

Apr 10, 2025
pulisher
Apr 10, 2025

Schroder Investment Management Group Sells 103,486 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

Novavax (NVAX) Shares Plunge After RFK Jr. Questions Its Covid Vaccine Efficacy - Bloomberg.com

Apr 10, 2025
pulisher
Apr 10, 2025

MRNA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Moderna, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

Is Moderna Stock A Sell After The FDA's 'Bloodbath?' - Investor's Business Daily

Apr 10, 2025

Moderna Inc Azioni (MRNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.04
price up icon 2.51%
$72.65
price up icon 3.49%
$32.60
price up icon 1.27%
$24.61
price up icon 6.77%
$98.76
price up icon 0.52%
biotechnology ONC
$230.98
price up icon 1.24%
Capitalizzazione:     |  Volume (24 ore):